Page last updated: 2024-12-07

4-nitrophenyl beta-d-xyloside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-nitrophenyl beta-D-xyloside : A xyloside that is beta-D-xylopyranose in which the anomeric hydroxy hydrogen is replaced by a 4-nitrophenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID91509
CHEBI ID90148
SCHEMBL ID110451
MeSH IDM0052677

Synonyms (48)

Synonym
4-nitrophenyl |a-d-xylopyranoside
beta-d-xyloside, 4-nitrophenyl
41721-77-1
p-nitrophenyl-beta-d-xyloside
nitrophenyl-beta-d-xyloside
2001-96-9
p-nitrophenyl beta-xylopyranoside
p-nitrophenol beta-d-xyloside
p-nitrophenyl beta-d-xyloside
beta-d-xylopyranoside, 4-nitrophenyl
beta-d-xylopyranoside, 4-nitrophenyl (9ci)
pnpx
xylopyranoside, p-nitrophenyl, beta-d- (8ci)
p-nitrophenyl beta-d-xylopyranoside
xylopyranoside, p-nitrophenyl (7ci)
p-nitrophenyl-beta-d-xylopyranoside
4-nitrophenyl beta-d-xylopyranoside
4-nitrophenyl beta-d-xyloside
4-nitrophenyl beta-d-xylopyranoside, >=98%
4-nitrophenyl-beta-d-xylopyranoside
N0620
(2s,3r,4s,5r)-2-(4-nitrophenoxy)oxane-3,4,5-triol
p-nitrophenyl-xyloside
nsc 371094
einecs 217-897-1
AKOS016015687
AKOS016009977
S12071
SCHEMBL110451
4-nitrophenyl b-d-xylopyranoside
3-nitrophenyl b-d-xylopyranoside
CHEBI:90148
4-nitrophenyl-i(2)-d-xylopyranoside
mfcd00047519
4-nitrophenyl-?-d-xylopyranoside
AS-61250
MLJYKRYCCUGBBV-YTWAJWBKSA-N
Q27162355
(2s,3r,4s,5r)-2-(4-nitrophenoxy)tetrahydropyran-3,4,5-triol
|a-d-xylopyranoside, 4-nitrophenyl
(2s,3r,4s,5r)-2-(4-nitrophenoxy)tetrahydro-2h-pyran-3,4,5-triol
4-nitrophenyl- beta -d- xylopyranoside
A879878
p-nitrophenyl ?-d-xylopyranoside
DTXSID801303045
p-nitrophenyl -d-xyloside
HY-W039938
CS-0098206

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Although all three stages could be observed in a given retina, a single stage typically predominated, depending on the particular dosage regimen."( Xyloside-induced disruption of interphotoreceptor matrix proteoglycans results in retinal detachment.
Hageman, GS; Lazarus, HS, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chromogenic compoundColourless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into coloured compounds. They are used in biochemical assays and in diagnosis as indicators, particularly in the form of enzyme substrates.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
xyloside
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (34.88)18.7374
1990's29 (33.72)18.2507
2000's16 (18.60)29.6817
2010's11 (12.79)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]